Skip to content
stoqly

Adient

ADNT NYSE Automotive Parts & Equipment Financials FY2016–FY2025

Adient's revenue fell 1.0% to $14.5 billion in fiscal 2025. Its net margin was βˆ’1.9%, down from 0.1% a year earlier. Free cash flow was $204 million, down 26.4%. It paid out $125 million in dividends and buybacks, 61% of free cash flow. The diluted share count fell 7.9%.

Last close Β· Oct 23, 2026

$16.61

3.4%
Revenue Total sales reported in the income statement.
$14.5B
1.0% vs prior year
Operating margin Operating income as a share of revenue.
β€”
Net income Profit after all expenses, interest and tax.
βˆ’$281M
1,661.1%
Free cash flow Cash from operations minus capital spending.
$204M
26.4%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
2.0%
4.1 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$1.3B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
30.2x
On $0.55 EPS (TTM)

What Adient does

No business description yet.

Legal name
Adient plc
Fiscal year ends
September 30, 2025
Latest annual report
β€”
Accession Β· CIK
0001670541-25-000152
0001670541

Revenue and margins

Adient had $14.5B of revenue in fiscal 2025, down 1.0% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $204M in fiscal 2025, 1.4% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Adient returned $125M to shareholders in fiscal 2025, 61% of free cash flow. The diluted share count fell 7.9%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Adient yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

Discounted cash flow

Value per share

β€”

Adds net cash of βˆ’$1.4B and divides by 83.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

β€”

Reference multiples: today 30.2x Β· peers 20.4x Β· sector 17.7x.

Balance sheet

Cash, debt and the ratios that show how comfortably Adient can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $1.5B$947M$1.1B$945M$958M
Debt incl. finance leases $3.7B$2.6B$2.5B$2.4B$2.4B
Net debt / EBITDA 1.1x2.7x1.9x2.2x3.4x
Debt / equity 1.6x1.2x1.1x1.1x1.4x
Interest coverage 7.3x1.3x3.2x1.7x0.5x
Current ratio 1.5x1.2x1.2x1.1x1.1x
Quick ratio 1.2x0.9x0.9x0.9x0.9x
Total assets $10.8B$9.2B$9.4B$9.4B$9.0B
Total liabilities $8.1B$6.8B$6.9B$6.9B$6.9B
Shareholders' equity $2.4B$2.1B$2.2B$2.1B$1.8B
Net debt (βˆ’ = net cash) $2.2B$1.6B$1.4B$1.5B$1.4B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.7M

4 insiders

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Sep 2, 2026 Peter CarlinDirector Sold 7,843 $19.25 $0.2M Form 4
Jun 4, 2026 David HerbergEVP, Emea Sold 699 $22.58 $0.0M Form 4
Jun 4, 2026 Heather M TiltmannEVP, CLO, CHRO & Secretary Sold 22,000 $22.71 $0.5M Form 4
Nov 26, 2025 Michel Pierre Rose BerthelinEVP, Emea Sold 2,500 $19.71 $0.0M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive βœ“ βœ“ βœ•
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ“ βœ• βœ•
Cash from operations exceeds net income βœ“ βœ“ βœ“
Debt fell relative to assets βœ• βœ“ βœ•
Current ratio rose βœ• βœ• βœ“
Share count didn't rise βœ• βœ“ βœ“
Gross margin rose βœ“ βœ• βœ“
Revenue rose relative to assets βœ“ βœ• βœ•
F-score 6 / 95 / 95 / 9
Accruals ratio βˆ’5.0%βˆ’5.6%βˆ’8.0%
Altman Z'' 0.780.580.29

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Adient ADNT $1.3B βˆ’1.0% β€” 1.4% 2.0% 30.2x 5
BorgWarner BWA $11.3B 1.6% 3.7% 8.2% 4.6% 27.1x 7 Compare β†’
Autoliv ALV $8.4B 4.1% 10.1% 6.6% 20.3% 13.8x 8 Compare β†’
Aptiv APTV $9.1B 3.5% 5.8% 7.5% 3.7% 40.3x 8 Compare β†’
Lear LEA $5.9B βˆ’0.2% 3.3% 2.3% 8.9% 10.9x 7 Compare β†’

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $16.8B $16.2B $17.4B $16.5B $12.7B $13.7B $14.1B $15.4B $14.7B $14.5B
Gross profit $1.6B $1.4B $904M $801M $592M $826M $807M $1.0B $928M $961M
Research and development $460M $488M $513M $454M $370M $316M $322M $362M $372M $387M
Interest expense $5.0M $129M $143M $137M $203M $229M $192M $132M $187M $183M
Pretax income $377M $1.1B βˆ’$1.1B $2.0M βˆ’$429M $1.4B $54.0M $295M $133M βˆ’$88.0M
Income tax $1.8B $99.0M $480M $410M $57.0M $249M $94.0M $0.0M $32.0M $103M
Net income βˆ’$1.5B $877M βˆ’$1.7B βˆ’$491M βˆ’$547M $1.1B βˆ’$120M $205M $18.0M βˆ’$281M
Diluted EPS βˆ’$16.50 $9.34 βˆ’$18.06 βˆ’$5.25 βˆ’$5.83 $11.58 βˆ’$1.27 $2.15 $0.20 βˆ’$3.39
Diluted shares 0.09B 0.09B 0.09B 0.09B 0.09B 0.10B 0.09B 0.10B 0.09B 0.08B
Cash flow
Cash from operations βˆ’$1.0B $746M $679M $308M $246M $260M $274M $667M $543M $449M
Capital expenditure $437M $577M $536M $468M $326M $260M $227M $252M $266M $245M
Free cash flow βˆ’$1.5B $169M $143M βˆ’$160M βˆ’$80.0M $0.0M $47.0M $415M $277M $204M
Depreciation and amortization $344M $358M $447M $318M $332M $330M $350M $340M $332M $325M
Stock-based compensation $28.0M $45.0M $47.0M $20.0M $15.0M $36.0M $29.0M $34.0M $31.0M $32.0M
Acquisitions $0.0M $247M $0.0M $0.0M $0.0M $211M $19.0M $6.0M $0.0M $0.0M
Share buybacks $0.0M $40.0M $0.0M $0.0M $0.0M $0.0M $0.0M $65.0M $275M $125M
Dividends paid $0.0M $52.0M $103M $26.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Dividends and buybacks $0.0M $92.0M $103M $26.0M $0.0M $0.0M $0.0M $65.0M $275M $125M
Balance sheet
Cash and short-term investments $105M $709M $687M $924M $1.7B $1.5B $947M $1.1B $945M $958M
Total debt $3.5B $3.5B $3.4B $3.7B $4.3B $3.7B $2.6B $2.5B $2.4B $2.4B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $1.0M $1.0M $0.0M $0.0M $0.0M
Current assets $5.7B $4.5B $4.3B $4.1B $4.5B $5.1B $4.2B $4.3B $4.1B $4.1B
Current liabilities $4.3B $4.3B $4.2B $3.8B $3.8B $3.5B $3.5B $3.7B $3.7B $3.7B
Inventory $660M $735M $824M $793M $685M $976M $953M $841M $758M $695M
Property and equipment, net $2.2B $2.5B $1.7B $1.7B $1.6B $1.6B $1.4B $1.4B $1.4B $1.4B
Total assets $13.0B $13.2B $10.9B $10.3B $10.3B $10.8B $9.2B $9.4B $9.4B $9.0B
Total liabilities $8.6B $8.6B $8.2B $8.2B $8.7B $8.1B $6.8B $6.9B $6.9B $6.9B
Shareholders' equity $4.2B $4.3B $2.4B $1.8B $1.2B $2.4B $2.1B $2.2B $2.1B $1.8B
Margins
Gross margin 9.6% 8.6% 5.2% 4.9% 4.7% 6.0% 5.7% 6.7% 6.3% 6.6%
EBITDA margin 4.3% 9.6% βˆ’3.0% 2.8% 0.8% 14.6% 4.2% 5.0% 4.4% 2.9%
Net margin βˆ’9.2% 5.4% βˆ’9.7% βˆ’3.0% βˆ’4.3% 8.1% βˆ’0.9% 1.3% 0.1% βˆ’1.9%
FCF margin βˆ’8.8% 1.0% 0.8% βˆ’1.0% βˆ’0.6% 0.0% 0.3% 2.7% 1.9% 1.4%
Returns
Return on capital β€” 14.3% βˆ’12.1% 1.3% βˆ’3.9% 30.5% 2.8% 10.7% 6.2% 2.0%
Return on capital employed β€” 13.6% βˆ’12.5% 2.1% βˆ’3.5% 24.3% 3.8% 7.5% 5.6% 1.7%
Return on equity βˆ’31.2% 20.8% βˆ’50.5% βˆ’23.2% βˆ’35.7% 61.7% βˆ’5.4% 9.5% 0.8% βˆ’14.4%
Return on assets βˆ’13.2% 6.7% βˆ’14.0% βˆ’4.6% βˆ’5.3% 10.5% βˆ’1.2% 2.2% 0.2% βˆ’3.1%
Growth
Revenue growth βˆ’16.2% βˆ’3.4% 7.6% βˆ’5.2% βˆ’23.3% 8.0% 3.2% 9.0% βˆ’4.6% βˆ’1.0%
Net income growth βˆ’436.1% β€” βˆ’292.1% β€” β€” β€” βˆ’110.8% β€” βˆ’91.2% βˆ’1,661.1%
EPS growth βˆ’436.7% β€” βˆ’293.4% β€” β€” β€” βˆ’111.0% β€” βˆ’90.7% βˆ’1,795.0%
FCF growth β€” β€” βˆ’15.4% βˆ’211.9% β€” β€” β€” 783.0% βˆ’33.3% βˆ’26.4%
Share count change βˆ’0.1% 0.2% βˆ’0.6% 0.3% 0.2% 2.0% βˆ’0.9% 0.6% βˆ’5.6% βˆ’7.9%
Financial health
Net debt / EBITDA 4.7x 1.8x β€” 6.2x 24.7x 1.1x 2.7x 1.9x 2.2x 3.4x
Debt / equity 0.8x 0.8x 1.4x 2.0x 3.6x 1.6x 1.2x 1.1x 1.1x 1.4x
Interest coverage 76.4x 9.2x βˆ’6.8x 1.0x βˆ’1.1x 7.3x 1.3x 3.2x 1.7x 0.5x
Current ratio 1.3x 1.0x 1.0x 1.1x 1.2x 1.5x 1.2x 1.2x 1.1x 1.1x
Quick ratio 1.2x 0.9x 0.8x 0.9x 1.0x 1.2x 0.9x 0.9x 0.9x 0.9x
Capital allocation
Capex / revenue 2.6% 3.6% 3.1% 2.8% 2.6% 1.9% 1.6% 1.6% 1.8% 1.7%
Stock comp / revenue 0.2% 0.3% 0.3% 0.1% 0.1% 0.3% 0.2% 0.2% 0.2% 0.2%
Payouts / FCF β€” 54.4% 72.0% β€” β€” β€” 0.0% 15.7% 99.3% 61.3%
Quality scores
Piotroski F-score β€” 4.0 4.0 5.0 3.0 7.0 4.0 6.0 5.0 5.0
Altman Z'' 1.5 1.4 βˆ’0.5 0.1 βˆ’0.2 2.1 0.6 0.8 0.6 0.3
Accruals ratio βˆ’4.4% 1.0% βˆ’19.6% βˆ’7.5% βˆ’7.7% 8.1% βˆ’4.0% βˆ’5.0% βˆ’5.6% βˆ’8.0%

Source: SEC EDGAR XBRL filings (CIK 0001670541). Data updated October 19, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open